Oxotremorine sesquifumarate cas no:17360-35-9

NameOxotremorine sesquifumarate
CAS17360-35-9
Synonyms1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinon(e)-2-butenedioate(2:3);1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinonfumarate(2:3);1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinonsesquifumarate;1-(n-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinonesesquifumarate;oxotremorinefumarate(2:3);1-[4-(1-PYRROLIDINYL)-2-BUTYNYL]-2-PYRROLIDINONE SESQUIFUMARATE;(1-[4-(1-PYRROLIDINYL)-2-BUTYNYL]-2-PYRROLIDINONE) SESQUIFUMARATE SALT;OXOTREMORINE SESQUIFUMARATE
EINECS(EC#)241-388-3
Molecular FormulaC12H18N2O . 3/2C4H4O4
Molecular Weight760.78

storage temp2-8°C

Hazardclass6.1(a)

Hazard T+
Risk 26/27/28
Safety

Hazard Codes: T+
Risk Statements: 26/27/28
R26/27/28: Oxotremorine sesquifumarate (CAS NO.17360-35-9) is very toxic by inhalation, in contact with skin and if swallowed.
Safety Statements: 28-36/37-45
S28: After contact with skin, wash immediately with plenty of soap-suds. 
S36/37: Wear suitable protective clothing and gloves. 
S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
RIDADR: UN 2811 6.1/PG 2
WGK Germany: 3
RTECS: UY6000000
HazardClass: 6.1(a)
PackingGroup: I
A poison by intraperitoneal and intravenous routes. When heated to decomposition it emits toxic vapors of NO_x.

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD50	intraperitoneal	6500ug/kg (6.5mg/kg)		Toxicology and Applied Pharmacology. Vol. 28, Pg. 227, 1974.
mouse	LD50	intravenous	20mg/kg (20mg/kg)		U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. Vol. NX#04243,